Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
Background Cell-based quadrivalent influenza vaccines (QIVc) can increase effectiveness against seasonal influenza by avoiding mismatch from egg adaption of vaccine viruses. This study evaluates the population-level cost-effectiveness and impacts on health outcomes of QIVc versus an egg-based vaccin...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Article |
| שפה: | אנגלית |
| יצא לאור: |
Taylor & Francis Group
2024-12-01
|
| סדרה: | Expert Review of Vaccines |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/14760584.2023.2295014 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|